TONIX PHARMACEUTICALS HOLDING CORP. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $1.26 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2021-11-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2021-11-08
- TONIX PHARMACEUTICALS HOLDING CORP. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2020-03-31 was $1.26M.
- TONIX PHARMACEUTICALS HOLDING CORP. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2019 was $2.47M, a 24.25% decline from fiscal 2018.
- TONIX PHARMACEUTICALS HOLDING CORP. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2018 was $3.27M.
- TONIX PHARMACEUTICALS HOLDING CORP. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2012 was $710.00K.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|
| 2020-03-31 | $1.26M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $2.47M 10-K · filed 2021-03-15 | |
| 2018-12-31 | $3.27M 10-K · filed 2020-03-24 | |
| 2012-12-31 | $710.00K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |